Association between secondary mutations in human immunodeficiency virus type 1 protease and therapeutic outcome

被引：6

作者：

Frater, J

Dunn, D

Weber, JN

McClure, MO

机构：

[1] Univ London Imperial Coll Sci Technol & Med, Div Med, Wright Fleming Inst, Jefferiss Res Labs, London W2 1PG, England

[2] MRC, HIV Clin Trials Unit, London, England

来源：

JOURNAL OF INFECTIOUS DISEASES | 2002年 / 185卷 / 09期

关键词：

D O I：

10.1086/340127

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1376 / 1376

页数：1

共 3 条

[1] Impact of baseline polymorphisms in RT and protease on outcome of highly active antiretroviral therapy in HIV-1-infected African patients [J].

Frater, AJ ;

Beardall, A ;

Ariyoshi, K ;

Churchill, D ;

Galpin, S ;

Clarke, JR ;

Weber, JN ;

McClure, MO .

AIDS, 2001, 15 (12) :1493-1502

[2]

FRATER AJ, 2001, 8 C RETR OPP INF CHI, P190

[3] Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy [J].

Perno, CF ;

Cozzi-Lepri, A ;

Balotta, C ;

Forbici, F ;

Violin, M ;

Bertoli, A ;

Facchi, G ;

Pezzotti, P ;

Cadeo, G ;

Tositti, G ;

Pasquinucci, S ;

Pauluzzi, S ;

Scalzini, A ;

Salassa, B ;

Vincenti, A ;

Phillips, AN ;

Dianzani, F ;

Appice, A ;

Angarano, G ;

Monno, L ;

Ippolito, G ;

Moroni, M ;

Monforte, AD .

JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (08) :983-991

← 1 →